Lazard Asset Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History
Bought
Maintained
Sold
Other funds holding RNLX
PA
LCS
TC
NCM
TCM
Lazard Asset Management's RNLX Position: Q3 2024 in Review
Lazard Asset Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q3 2024, closing a stake of 681 shares.
Lazard Asset Management first reported a position in RNLX in Q1 2021 and held it in 14 quarters. The position peaked at $2M in Q4 2021. 24 funds tracked by Wall St. Rank hold RNLX as of Q3 2024.
- Lazard Asset Management reported no remaining Renalytix plc American Depositary Shares position as of Q3 2024 after selling out during the quarter.
- Lazard Asset Management sold 681 Renalytix plc American Depositary Shares shares in Q3 2024.
- Lazard Asset Management first reported a position in Renalytix plc American Depositary Shares in Q1 2021 and held it in 14 quarters.
- Lazard Asset Management's Renalytix plc American Depositary Shares position peaked at $2M in Q4 2021.
- 24 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2024.
Based on Lazard Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.